Interventions

Experimental Arm
The experimental arm will involve midodrine administration 10mg enterally q8h from time of study inclusion to 24 hours post IV vasopressor support termination. This will be administered as a capsule containing the active substance. There is no maximum duration of treatment.

Control Arm
Participants in the control arm will receive a placebo capsule to match the midodrine. Participants will be given the placebo enterally q8h from time of study inclusion to 24 hours post IV vasopressor support termination. This will be administered as a capsule containing the inactive substance.